Aehr Test Systems (AEHR) Beta: Monthly Comparison and Analysis

Aehr Test Systems (NASDAQ: AEHR) closed the day trading at $16.18 up 2.02% from the previous closing price of $15.86. In other words, the price has increased by $+0.32 from its previous closing price. On the day, 676831 shares were traded.

Ratios:

For a better understanding of AEHR, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 9.24 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 72.94. For the most recent quarter (mrq), Quick Ratio is recorded 7.28 and its Current Ratio is at 11.53. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.07.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 18 when Erickson Gayn sold 4,871 shares for $17.39 per share. The transaction valued at 84,726 led to the insider holds 427,935 shares of the business.

ROGERS VERNON sold 1,309 shares of AEHR for $22,769 on Jan 18. The Exec VP of Sales & Mktg. now owns 40,277 shares after completing the transaction at $17.39 per share. On Jan 18, another insider, RICHMOND DONALD P. II, who serves as the CTO of the company, sold 1,021 shares for $17.39 each. As a result, the insider received 17,759 and left with 175,232 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AEHR now has a Market Capitalization of 466.78M and an Enterprise Value of 422.68M. As of this moment, Aehr’s Price-to-Earnings (P/E) ratio for their current fiscal year is 22.80, and their Forward P/E ratio for the next fiscal year is 11.81. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.14. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.73 while its Price-to-Book (P/B) ratio in mrq is 5.35. Its current Enterprise Value per Revenue stands at 5.18 whereas that against EBITDA is 21.67.

Stock Price History:

Over the past 52 weeks, AEHR has reached a high of $54.10, while it has fallen to a 52-week low of $14.54. The 50-Day Moving Average of the stock is 20.33, while the 200-Day Moving Average is calculated to be 33.80.

Shares Statistics:

Over the past 3-months, AEHR traded about 1.56M shares per day on average, while over the past 10 days, AEHR traded about 1.51M shares per day. A total of 28.54M shares are outstanding, with a floating share count of 27.05M. Insiders hold about 6.25% of the company’s shares, while institutions hold 68.41% stake in the company. Shares short for AEHR as of Jan 31, 2024 were 6.02M with a Short Ratio of 3.86, compared to 6.16M on Dec 29, 2023. Therefore, it implies a Short% of Shares Outstanding of 20.87% and a Short% of Float of 22.00%.

Earnings Estimates

Current recommendations for the stock of the company come from 2 analysts. On average, analysts expect EPS of $0.13 for the current quarter, with a high estimate of $0.17 and a low estimate of $0.09, while EPS last year was $0.16. The consensus estimate for the next quarter is $0.23, with high estimates of $0.25 and low estimates of $0.22.

Analysts are recommending an EPS of between $0.8 and $0.73 for the fiscal current year, implying an average EPS of $0.76. EPS for the following year is $1.37, with 2 analysts recommending between $1.74 and $1.

Revenue Estimates

A total of 2 analysts have provided revenue estimates for AEHR’s current fiscal year. The highest revenue estimate was $79.67M, while the lowest revenue estimate was $75.16M, resulting in an average revenue estimate of $77.41M. In the same quarter a year ago, actual revenue was $64.96M, up 19.20% from the average estimate. Based on 2 analysts’ estimates, the company’s revenue will be $136.04M in the next fiscal year. The high estimate is $168.52M and the low estimate is $103.57M. The average revenue growth estimate for next year is up 75.70% from the average revenue estimate for this year.

Most Popular

[the_ad id="945"]